13F-HR filed by MPM BIOIMPACT LLC
MPM BIOIMPACT LLC filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 38 holding rows worth $873,953,483.
- Accession
- 0001193125-26-054813
- Filer
- CIK 1687078
- Filed
- 2026-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 38 entries on the cover page, a total value of $873,953,483 stated on the cover page (in dollars after the unit check, H1), rows summing to $873,953,483 with VALUE read as dollars as filed, 13F file number 028-20107. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 7,648,268 | $79,159,574 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 96,780 | $56,358,865 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 1,400,869 | $48,315,972 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 3,287,087 | $41,154,329 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 1,655,256 | $41,075,178 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 505,672 | $40,276,775 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 1,303,373 | $35,477,813 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 1,381,628 | $33,062,358 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 430,013 | $32,663,787 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,337,702 | $28,105,119 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 1,405,388 | $27,489,389 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 328,869 | $26,927,794 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 770,289 | $24,448,973 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 2,401,992 | $23,443,442 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 941,378 | $22,047,073 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 485,620 | $21,765,488 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 205,745 | $21,535,329 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 93,551 | $21,431,599 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 2,743,671 | $21,126,267 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J309 | SPONSORED ADS | 996,825 | $19,109,135 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 2,232,451 | $18,886,535 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 1,173,376 | $18,398,536 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 230,147 | $17,960,672 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 199,471 | $17,421,797 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 1,840,898 | $16,623,309 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 10,679,391 | $15,698,705 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 531,200 | $15,426,048 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 1,639,061 | $14,800,721 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,798,717 | $14,713,505 | dollars as filed | |
| BELITE BIO INC | 07782B104 | CMN | 87,760 | $14,038,090 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E208 | COM NEW | 397,906 | $13,477,076 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 2,671,480 | $10,685,920 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 56,316 | $7,594,494 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,586,076 | $5,567,127 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 81,145 | $3,361,837 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 113,022 | $1,934,937 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 70,000 | $1,506,400 | dollars as filed | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 1,393,557 | $883,515 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001193125-26-054813 | this filing | 2026-02-17 | acceptance time not in the bulk data set |